Paper23770577
Histological and immunohistochemical profiles predict lymph node status in women with low-intermediate risk endometrial cancer.
Ballester M and 7 others. Gynecol Oncol, 2013. Cited by 24 papers, by iCite.
Cite this record
ConductScience Library. Histological and immunohistochemical profiles predict lymph node status in women with low-intermediate risk endometrial cancer. Papers, record 23770577. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23770577
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Histological and immunohistochemical profiles predict lymph node status in women with low-intermediate risk endometrial cancer.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Endometrial Neoplasms | Major topic |
| Receptors, Estrogen | Major topic |
| Receptors, Progesterone | Major topic |
| Blood Vessels | |
| Female | |
| Humans | |
| Lymphatic Metastasis | |
| Lymphatic Vessels | |
| Neoplasm Grading | |
| Neoplasm Invasiveness | |
| Risk Factors |
Source PubMed
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42325994 | Risk Factors for the Prognosis of Endometrioid Endometrial Cancer: A Chinese Cohort Study. | Obstet Gynecol Int | 2026 | https://conductscience.org/library/papers/42325994 | PubMed |
| 39687493 | Prognostic and clinicopathological significance of survivin in gynecological cancer. | Oncol Rev | 2024 | https://conductscience.org/library/papers/39687493 | PubMed |
| 39682221 | Evaluation of Different Risk Factors for Metastatic Sentinel Lymph Nodes in Endometrial Cancer. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39682221 | PubMed |
| 36908008 | The expression of stanniocalcin-1, estrogen receptor and progesterone receptor in endometrioid endometrial cancer. | Turk J Obstet Gynecol | 2023 | https://conductscience.org/library/papers/36908008 | PubMed |
| 36077609 | Improving Risk Assessment for Metastatic Disease in Endometrioid Endometrial Cancer Patients Using Molecular and Clinical Features: An NRG Oncology/Gynecologic Oncology Group Study. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36077609 | PubMed |
| 35721388 | Estrogen Receptor- And Progesterone Receptor-Positive Thresholds in Predicting the Recurrence of Early Low-Risk Endometrial Cancer. | Clin Med Insights Oncol | 2022 | https://conductscience.org/library/papers/35721388 | PubMed |
| 35453837 | Quantitative Measurement of Progesterone Receptor Immunohistochemical Expression to Predict Lymph Node Metastasis in Endometrial Cancer. | Diagnostics (Basel) | 2022 | https://conductscience.org/library/papers/35453837 | PubMed |
| 34495379 | Developing a validated nomogram for predicting ovarian metastasis in endometrial cancer patients: a retrospective research. | Arch Gynecol Obstet | 2022 | https://conductscience.org/library/papers/34495379 | PubMed |
| 34422634 | Combining Clinicopathological Parameters and Molecular Indicators to Predict Lymph Node Metastasis in Endometrioid Type Endometrial Adenocarcinoma. | Front Oncol | 2021 | https://conductscience.org/library/papers/34422634 | PubMed |
| 34413681 | Analysis of Factors Related to Lymph Node Metastasis in Early-Stage Type 1 Endometrial Cancer: Verifying the Clinical Value of Positive Threshold of the Immunohistochemical Parameter Ki67. | Cancer Manag Res | 2021 | https://conductscience.org/library/papers/34413681 | PubMed |
| 34134781 | Immunotherapy in endometrial cancer: rationale, practice and perspectives. | Biomark Res | 2021 | https://conductscience.org/library/papers/34134781 | PubMed |
| 27163153 | Predicting Lymph Node Metastasis in Endometrial Cancer Using Serum CA125 Combined with Immunohistochemical Markers PR and Ki67, and a Comparison with Other Prediction Models. | PLoS One | 2016 | https://conductscience.org/library/papers/27163153 | PubMed |
| 25675149 | Just how accurate are the major risk stratification systems for early-stage endometrial cancer? | Br J Cancer | 2015 | https://conductscience.org/library/papers/25675149 | PubMed |
| 25406186 | Role of nuclear progesterone receptor isoforms in uterine pathophysiology. | Hum Reprod Update | 2015 | https://conductscience.org/library/papers/25406186 | PubMed |
| 24809776 | A clue towards improving the European Society of Medical Oncology risk group classification in apparent early stage endometrial cancer? Impact of lymphovascular space invasion. | Br J Cancer | 2014 | https://conductscience.org/library/papers/24809776 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ESR1 | 2099 | PubTator's text mining | https://conductscience.org/library/genes/2099 | NCBI Gene |
| PGR | 5241 | PubTator's text mining | https://conductscience.org/library/genes/5241 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23770577
GET https://conductscience.org/api/papers/v1/23770577/authors